Diabetic retinopathy is the leading cause of blindness in working-age adults in the U.S. and is a complication of diabetes.

Exonate has announced plans to initiate a phase 2b clinical trial of its lead candidate EXN407, a topical SRPK1 inhibitor, ...

Exonate Ltd., a biotechnology company developing novel, non-invasive, small-molecule therapeutics for patients with retinal vascular diseases, today announced plans to initiate a Phase IIb clinical ...

More than 98 lakh cataract surgeries were performed in the fiscal year 2024-25, said Union Minister of State for Health and ...

Avant Technologies Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an emerging technology company developing healthcare solutions, and its Joint Venture partner, Ainnova Tech, Inc. (Ainnova), a leading ...

Resistant hypertension happens when your blood pressure is higher than normal, even though you are taking at least three ...

Avant Technologies Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an emerging technology company developing healthcare ...

As European markets experience tentative optimism due to potential trade agreements with the U.S., and the European Central Bank maintains a steady interest rate, investors are keenly observing ...

Here, readers share a warning about the Trump Administration and praise Mike Kelly's support for seniors' medical access.

Equity Insider News CommentaryIssued on behalf of Avant Technologies Inc. VANCOUVER, BC, July 29, 2025 /PRNewswire/ -- Equity Insider News Commentary - There's a lot of big ...

The government has partnered with Orbis International to strengthen specialised eye care services in the country, focusing on advanced technology and capacity building for medical personnel, officials ...

The National Road Safety Foundation says the time between Memorial Day and Labor Day is known as the 100 deadliest days ...